Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG
Award amount
$149,850Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- TRACE-ABILITY INC
- Proposal award date
- 2015-02-06
- Contract end date
- 2015-12-31
- UEI
- S11KA2DGF4J6
- Solicitation number
- PA14-071
- Topic code
- 394
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.
- Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
- Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
- Rapid pre-release sterility test for PET Drugs.
- Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Deep Learning Serial Radiomics for Improved Cancer Therapy Response Assessment.
- Prospective validation of a radiomics-based multi-modal predictive model for metastatic non-small cell lung cancer patients treated with PD-1 immunotherapy
- Fluorescence lifetime imaging device for 5-ALA-guided neurosurgery
- Simple and Accessible Microfluidic Platform for Single Molecule Sequence Profiling of Tumor-derived DNA within Liquid Biopsies
- AI-based AML risk stratification using next generation cytogenomics
Research funding history
14 SBIR/STTR records share this UEI (2015–2024). Reported award amounts total $13,965,661. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, National Science Foundation